Allogene Therapeutics Reports First Quarter 2022 Financial Results

Go back to Allogene Therapeutics Reports First Quarter 2022 Financial Results
(NASDAQ: ALLO) Delayed: 2.03 --0 (-0%)
Previous Close $2.03    52 Week High
Open $2.03    52 Week Low
Day High $2.03    P/E N/A 
Day Low $2.03    EPS
Volume 23,143